Orlandi, A., Iattoni, E., Pizzuti, L., Fabbri, A., Botticelli, A., Di Dio, C., . . . Tortora, G. (2020). Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †. J Pers Med.
Citação norma ChicagoOrlandi, Armando, et al. "Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer With Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †." J Pers Med 2020.
Citação norma MLAOrlandi, Armando, et al. "Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer With Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †." J Pers Med 2020.